阿尔茨海默病中的G蛋白信号传递:半监督的基于深度学习的计算框架的空间表达验证
Daniel F Zhang1,2, Timothy Penwell1, Yan-Hua Chen1,3,4
1Department of Anatomy and Cell Biology, Brody School of Medicine, East Carolina University, Greenville, North Carolina 27834.
概括
一个新的计算框架,digID,确定了1529个阿尔茨海默病 (AD) 基因,揭示了潜在的治疗点,如AD治疗的GNAI1,GNB1和KNG1.
科学领域:
- 基因组学就是基因组学.
- 计算生物学 计算生物学
- 神经科学是一个神经科学.
背景情况:
- 了解阿尔茨海默氏症 (AD) 病原体需要研究基因相互作用.
- 大规模的多组数据集为AD相关基因的计算分析提供了机会.
- 确定新的治疗点对于有效的AD治疗至关重要.
研究的目的:
- 开发一个计算框架 (digID) 来预测AD相关基因.
- 确定阿尔茨海默病的新型分子机制和治疗点.
- 使用蛋白质-蛋白质相互作用网络分析来优先预测AD基因.
主要方法:
- 开发了一种新型疾病基因识别 (digID) 框架.
- 采用半监督深度学习分类器来预测AD相关基因.
- 利用蛋白质与蛋白质相互作用 (PPI) 网络分析来确定基因优先级.
主要成果:
- 预测了1529个与AD相关的基因,包括GNAI1,GNB1和KNG1.
- 确定了潜在的新的AD分子机制和治疗点.
- 在AD大脑中使用mRNA表达和STORM成像在小鼠模型中验证了基因失调.
结论:
- digID框架成功预测了与AD相关的基因.
- GNAI1,GNB1和KNG1代表了阿尔茨海默病的潜在新型治疗点.
- 生物验证对于计算识别的基因集群作为治疗点至关重要.
更多相关视频
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


